Immediate Impact
3 standout
Citing Papers
Interstitial Lung Disease
2024 Standout
TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases
2023 Standout
Works of Jonathan Schelfhout being referenced
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
2022 Standout
Prevalence and Burden of Chronic Cough in the United States
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jonathan Schelfhout | 582 | 504 | 119 | 204 | 52 | 711 | |
| Xianghuai Xu | 519 | 314 | 293 | 84 | 73 | 645 | |
| Ha‐Kyeong Won | 410 | 455 | 48 | 133 | 40 | 706 | |
| Sung‐Yoon Kang | 377 | 386 | 41 | 126 | 63 | 645 | |
| Jason Powell | 373 | 172 | 81 | 32 | 48 | 837 | |
| Rosana Câmara Agondi | 402 | 455 | 15 | 34 | 36 | 693 | |
| Matthew G. Marin | 409 | 229 | 6 | 76 | 36 | 779 | |
| Kang‐Cheng Su | 465 | 354 | 42 | 22 | 43 | 710 | |
| Alessandro Bodini | 450 | 480 | 15 | 51 | 33 | 770 | |
| Julian McGlashan | 278 | 250 | 144 | 37 | 51 | 619 | |
| Brett Haumann | 680 | 630 | 9 | 19 | 29 | 777 |
All Works
Loading papers...